Sage Therapeutics Inc (SAGE)
5.45
-0.16
(-2.85%)
USD |
NASDAQ |
Dec 23, 11:27
Sage Therapeutics Cash from Investing (Quarterly): 81.05M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Outset Medical Inc | 15.88M |
| Biogen Inc | -1.181B |
| Johnson & Johnson | -3.128B |
| Lifecore Biomedical Inc | -3.392M |
| Poseida Therapeutics Inc | 27.65M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -82.36M |
| Cash from Financing (Quarterly) | 1.037M |
| Free Cash Flow | -320.15M |
| Free Cash Flow Per Share (Quarterly) | -1.348 |
| Free Cash Flow to Equity (Quarterly) | -82.36M |
| Free Cash Flow Yield | -97.19% |